Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma
Autor: | Kar-Wai Lui, Wei Teng, Shi-Ming Lin, Yi-Chung Hsieh, Ya-Ting Cheng, Wei-Ting Chen, Chen-Chun Lin |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Carcinoma Hepatocellular Radiofrequency ablation Ablation Techniques medicine.medical_treatment Lower risk 030218 nuclear medicine & medical imaging law.invention 03 medical and health sciences 0302 clinical medicine law Humans Medicine Radiology Nuclear Medicine and imaging Retrospective Studies Radiofrequency Ablation medicine.diagnostic_test business.industry Liver Neoplasms Hazard ratio Interventional radiology General Medicine medicine.disease Ablation BCLC Stage Treatment Outcome surgical procedures operative 030220 oncology & carcinogenesis Hepatocellular carcinoma Catheter Ablation Radiology business therapeutics |
Zdroj: | European Radiology. 31:8649-8661 |
ISSN: | 1432-1084 0938-7994 |
DOI: | 10.1007/s00330-021-07729-9 |
Popis: | Radiofrequency ablation (RFA) of medium-sized (3–5 cm) hepatocellular carcinoma (HCC) is suboptimal. Switching monopolar RFA (SW-RFA) enlarges the ablative volume to better cover larger tumors. This study aims to compare the long-term outcomes of medium-sized HCC treated by either SW-RFA or single-monopolar RFA (S-RFA). We retrospectively reviewed 139 cases (147 medium-size HCC) between 2008 and 2014. Under propensity score matching, a total of 43 paired patients with medium-size HCC and balanced clinical variables treated by either SW-RFA or S-RFA were selected for comparison. SW-RFA showed a higher rate of achieving an adequate safety margin (p = 0.002). After a mean follow-up period of 40.4 months, SW-RFA produced significantly lower global RFA failure rates (p < 0.001) and better overall survival (p = 0.005) compared to S-RFA. SW-RFA was independently associated with a decreased risk of global RFA failure (hazard ratio [HR]: 0.136, 95% confidence interval [CI]: 0.030–0.607, p = 0.009) and improved overall survival (HR: 0.337, 95% CI: 0.152–0.747, p = 0.007). By last follow-up, the SW-RFA group maintained a superior tumor-free rate (p = 0.010) and fewer progressions to Barcelona Clinic Liver Cancer stage C (p = 0.011). Major complication rates were comparable in both groups (SW-RFA: 2.3% vs. S-RFA: 4.7%, p = 1.000). The switching multi-monopolar ablation technique could be beneficial for patients with medium-sized HCCs given sustained control of larger tumors with better overall survival. • Switching monopolar ablation could provide a sustained local tumor control and better overall survival than single-monopolar ablation for the medium-sized hepatocellular carcinoma. • Compared to single-monopolar ablation, switching monopolar ablation could create a larger homogeneous coagulation volume by using a shorter total ablation time to achieve a higher rate of adequate safety margin for a medium-sized HCC. • Patients with medium-sized HCC can be maintained at a higher rate of tumor-free status and at a lower risk of progression into BCLC stage C in the follow-up period after ablation by switching monopolar than by single-monopolar ablation. |
Databáze: | OpenAIRE |
Externí odkaz: |